Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis
Journal of Dermatological Treatment , 10/23/08
Mraz S et al. - The majority of adverse events for both products were mild in severity. Thus, while both of these formulations contain the same active ingredient at the same concentration, differences in their efficacy were observed when each treatment was used within its approved labeling guidelines.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Anti-platelet Agents
Discovery Medicine, 12/15/09
Use of oral bisphosphonates and risk of venous thromboembolism: A population-based case-control study
Osteoporosis International, 12/15/09
Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up
Acta Neurologica Scandinavica, 12/15/09
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
Journal of the National Cancer Institute, 12/15/09
Clinically relevant drug interactions of current antifungal agents
Mycoses, 12/15/09
Formalin deposition as artifact in biopsies from patients affected by a new variant of endemic pemphigus foliaceus in El Bagre, Colombia, South America
Journal of Cutaneous Pathology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


